Differences in pharmacokinetic profiles between long-term kidney/pancreas and non-diabetic kidney transplant patients on tacrolimus and mycophenolate mofetil.

被引：0
|
作者：
Cantarovich, M [1 ]
Paraskevas, S [1 ]
Keith, D [1 ]
Lipman, M [1 ]
Mangel, R [1 ]
Fontaine, G [1 ]
Metrakos, P [1 ]
Tchervenkov, J [1 ]
机构：
[1] McGill Univ, Ctr Hlth, Multi Organ Transplant Program, Montreal, PQ, Canada
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2005年 / 5卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
687
引用
收藏
页码：331 / 331
页数：1
相关论文
共 50 条
  • [21] LONG-TERM OUTCOMES OF STEROID WITHDRAWAL BETWEEN 3 AND 6 MONTHS AFTER KIDNEY TRANSPLANTATION WITH INDUCTION THERAPY AND TACROLIMUS AND MYCOPHENOLATE MOFETIL
    Hwang, Subin
    Kim, Jinhae
    Park, Jeeeun
    Jang, Hye Ryoun
    Lee, Jung Eun
    Kim, Yoon-Goo
    Kim, Dae Joong
    Oh, Ha Young
    Huh, Wooseong
    TRANSPLANT INTERNATIONAL, 2017, 30 : 480 - 480
  • [22] Long-term kidney and pancreas function with tacrolimus immunosuppression following simultaneous kidney and pancreas transplantation (SKP).
    Peddi, VR
    Demmy, AM
    Munda, R
    Alexander, JW
    First, MR
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A3244 - A3244
  • [23] Long-Term Mycophenolate Mofetil Treatment in Pediatric Renal Transplant Patients
    Roberts, John P.
    Potter, Donald
    Bouw, M. Rene
    DIALYSIS & TRANSPLANTATION, 2009, 38 (11) : 445 - +
  • [24] The role of antibody induction in simultaneous pancreas kidney (SPK) transplant patients receiving Tacrolimus plus mycophenolate mofetil (MMF) immunosuppression.
    Kaufman, DB
    Burke, G
    Bruce, D
    Sutherland, D
    Johnson, C
    Gaber, AO
    Merion, R
    Schweitzer, E
    Marsh, C
    Alfrey, E
    Leone, J
    Concepion, W
    Stegall, M
    Gores, P
    Danovitch, G
    Tolzman, D
    Scotellaro, P
    Salm, K
    Keller, A
    Fitzsimmons, WE
    TRANSPLANTATION, 2000, 69 (08) : S206 - S206
  • [25] Ganciclovir prophylaxis for cytomegalovirus infection in simultaneous kidney-pancreas transplant recipients receiving tacrolimus, mycophenolate mofetil, and prednisone
    Lo, A
    Stratta, RJ
    Egidi, MF
    Kizilisik, AT
    Shokouh-Amiri, MH
    Grewal, HP
    Trofe, J
    Alloway, RR
    Gaber, AO
    TRANSPLANTATION PROCEEDINGS, 2001, 33 (1-2) : 1796 - 1798
  • [26] Long-term graft outcome with mycophenolate mofetil and azathioprine: A paired kidney analysis
    Shah, Sapna
    Collett, Dave
    Johnson, Rachel
    Thuraisingham, Raj C.
    Raftery, Martin J.
    Rudge, Chris J.
    Yaqoob, Muhammad M.
    TRANSPLANTATION, 2006, 82 (12) : 1634 - 1639
  • [27] Simultaneous use of tacrolimus and mycophenolate mofetil in combined pancreas-kidney transplant recipients: A multi-center report
    Stratta, RJ
    TRANSPLANTATION PROCEEDINGS, 1997, 29 (1-2) : 654 - 655
  • [28] LONG TERM GRAFT FUNCTION IN PEDIATRIC RENAL TRANSPLANT PATIENTS WITH CHRONIC ALLOGRAFT NEPHROPATHY RECEIVING MYCOPHENOLATE MOFETIL.
    Prince, Nicholas J.
    McCulloch, Mignon I.
    Kerecuk, Larissa
    Walsh, Grainne
    Taylor, Judy
    PEDIATRIC TRANSPLANTATION, 2011, 15 : 56 - 56
  • [29] Genetic predictors of long-term graft function in kidney and pancreas transplant patients
    Duff, Claire E.
    Simmonds, Matthew J.
    BRIEFINGS IN FUNCTIONAL GENOMICS, 2017, 16 (04) : 228 - 237
  • [30] Long-term administration of enteric-coated mycophenolate sodium in kidney transplant patients
    Salvadori, M
    TRANSPLANTATION PROCEEDINGS, 2005, 37 (02) : 909 - 911
12345